CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,291,183 | -9.7% | 111,717 | 0.0% | 0.31% | +5.8% |
| Q2 2023 | $3,644,209 | -7.3% | 111,717 | 0.0% | 0.29% | -9.8% |
| Q1 2023 | $3,931,321 | -23.2% | 111,717 | 0.0% | 0.33% | -25.2% |
| Q4 2022 | $5,118,873 | -5.4% | 111,717 | 0.0% | 0.44% | +1.9% |
| Q3 2022 | $5,413,000 | +23.3% | 111,717 | 0.0% | 0.43% | +11.7% |
| Q2 2022 | $4,389,000 | +6.7% | 111,717 | 0.0% | 0.38% | +20.4% |
| Q1 2022 | $4,112,000 | -27.1% | 111,717 | -9.7% | 0.32% | -11.7% |
| Q4 2021 | $5,638,000 | +27.5% | 123,686 | 0.0% | 0.36% | +34.8% |
| Q3 2021 | $4,421,000 | +80.6% | 123,686 | 0.0% | 0.27% | +97.8% |
| Q2 2021 | $2,448,000 | -14.9% | 123,686 | 0.0% | 0.14% | -17.7% |
| Q1 2021 | $2,877,000 | +11.9% | 123,686 | 0.0% | 0.16% | +21.5% |
| Q4 2020 | $2,570,000 | -4.0% | 123,686 | 0.0% | 0.14% | -8.2% |
| Q3 2020 | $2,678,000 | -8.1% | 123,686 | 0.0% | 0.15% | -16.0% |
| Q2 2020 | $2,915,000 | +99.9% | 123,686 | 0.0% | 0.18% | +43.4% |
| Q1 2020 | $1,458,000 | +11.1% | 123,686 | 0.0% | 0.12% | +69.4% |
| Q4 2019 | $1,312,000 | -6.8% | 123,686 | 0.0% | 0.07% | -23.4% |
| Q3 2019 | $1,408,000 | +1.2% | 123,686 | 0.0% | 0.09% | +38.2% |
| Q2 2019 | $1,391,000 | +39.0% | 123,686 | 0.0% | 0.07% | +61.9% |
| Q1 2019 | $1,001,000 | +28.0% | 123,686 | 0.0% | 0.04% | 0.0% |
| Q4 2018 | $782,000 | -35.8% | 123,686 | 0.0% | 0.04% | -14.3% |
| Q3 2018 | $1,218,000 | +18.6% | 123,686 | 0.0% | 0.05% | +19.5% |
| Q2 2018 | $1,027,000 | +15.3% | 123,686 | 0.0% | 0.04% | +7.9% |
| Q1 2018 | $891,000 | -11.6% | 123,686 | 0.0% | 0.04% | -11.6% |
| Q4 2017 | $1,008,000 | -43.8% | 123,686 | 0.0% | 0.04% | -43.4% |
| Q3 2017 | $1,793,000 | +19.8% | 123,686 | 0.0% | 0.08% | +8.6% |
| Q2 2017 | $1,497,000 | -5.8% | 123,686 | 0.0% | 0.07% | -6.7% |
| Q1 2017 | $1,589,000 | +5.7% | 123,686 | 0.0% | 0.08% | -12.8% |
| Q4 2016 | $1,503,000 | +32.4% | 123,686 | 0.0% | 0.09% | +30.3% |
| Q3 2016 | $1,135,000 | -3.3% | 123,686 | 0.0% | 0.07% | -25.8% |
| Q2 2016 | $1,174,000 | +34.6% | 123,686 | 0.0% | 0.09% | +30.9% |
| Q1 2016 | $872,000 | -32.6% | 123,686 | 0.0% | 0.07% | -5.6% |
| Q4 2015 | $1,294,000 | +56.5% | 123,686 | 0.0% | 0.07% | +80.0% |
| Q3 2015 | $827,000 | -0.5% | 123,686 | 0.0% | 0.04% | +8.1% |
| Q2 2015 | $831,000 | -1.0% | 123,686 | 0.0% | 0.04% | -9.8% |
| Q1 2015 | $839,000 | -15.3% | 123,686 | 0.0% | 0.04% | -29.3% |
| Q4 2014 | $991,000 | +127.8% | 123,686 | 0.0% | 0.06% | +81.2% |
| Q3 2014 | $435,000 | -26.4% | 123,686 | 0.0% | 0.03% | -27.3% |
| Q2 2014 | $591,000 | -87.4% | 123,686 | -75.0% | 0.04% | -77.3% |
| Q1 2014 | $4,696,000 | +210.4% | 494,372 | +112.4% | 0.19% | +37.6% |
| Q4 2013 | $1,513,000 | – | 232,808 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |